A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care

Background: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms, respectively. The pacing function may be ver...

Full description

Bibliographic Details
Main Authors: Holly Standing, Catherine Exley, Darren Flynn, Julian Hughes, Kerry Joyce, Trudie Lobban, Stephen Lord, Daniel Matlock, Janet M McComb, Paul Paes, Richard G Thomson
Format: Article
Language:English
Published: NIHR Journals Library 2016-10-01
Series:Health Services and Delivery Research
Online Access:https://doi.org/10.3310/hsdr04320
id doaj-52bb92faeab9435185bd2c1cdfd072fe
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Holly Standing
Catherine Exley
Darren Flynn
Julian Hughes
Kerry Joyce
Trudie Lobban
Stephen Lord
Daniel Matlock
Janet M McComb
Paul Paes
Richard G Thomson
spellingShingle Holly Standing
Catherine Exley
Darren Flynn
Julian Hughes
Kerry Joyce
Trudie Lobban
Stephen Lord
Daniel Matlock
Janet M McComb
Paul Paes
Richard G Thomson
A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
Health Services and Delivery Research
author_facet Holly Standing
Catherine Exley
Darren Flynn
Julian Hughes
Kerry Joyce
Trudie Lobban
Stephen Lord
Daniel Matlock
Janet M McComb
Paul Paes
Richard G Thomson
author_sort Holly Standing
title A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
title_short A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
title_full A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
title_fullStr A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
title_full_unstemmed A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
title_sort qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
publisher NIHR Journals Library
series Health Services and Delivery Research
issn 2050-4349
2050-4357
publishDate 2016-10-01
description Background: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms, respectively. The pacing function may be very sophisticated and can provide so-called cardiac resynchronisation therapy for the treatment of heart failure using a pacemaker (cardiac resynchronisation therapy with pacemaker) or combined with an ICD [cardiac resynchronisation therapy with defibrillator (CRT-D)]. Decision-making about these devices involves considering the benefit (averting sudden cardiac death), possible risks (inappropriate shocks and psychological problems) and the potential need for deactivation towards the end of life. Objectives: To explore patients’/relatives’ and clinicians’ views/experiences of decision-making about ICD and CRT-D implantation and deactivation, to establish how and when ICD risks, benefits and consequences are communicated to patients, to identify individual and organisational facilitators and barriers to discussions about implantation and deactivation and to determine information and decision-support needs for shared decision-making (SDM). Data sources: Observations of clinical encounters, in-depth interviews and interactive group workshops with clinicians, patients and their relatives. Methods: Observations of consultations with patients being considered for ICD or CRT-D implantation were undertaken to become familiar with the clinical environment and to optimise the sampling strategy. In-depth interviews were conducted with patients, relatives and clinicians to gain detailed insights into their views and experiences. Data collection and analysis occurred concurrently. Interactive workshops with clinicians and patients/relatives were used to validate our findings and to explore how these could be used to support better SDM. Results: We conducted 38 observations of clinical encounters, 80 interviews (44 patients/relatives, seven bereaved relatives and 29 clinicians) and two workshops with 11 clinicians and 11 patients/relatives. Patients had variable knowledge about their conditions, the risk of sudden cardiac death and the clinical rationale for ICDs, which sometimes resulted in confusion about the potential benefits. Clinicians used various metaphors, verbal descriptors and numerical risk methods, including variable disclosure of the potential negative impact of ICDs on body image and the risk of psychological problems, to convey information to patients/relatives. Patients/relatives wanted more information about, and more involvement in, deactivation decisions, and expressed a preference that these decisions be addressed at the time of implantation. There was no consensus among clinicians about the initiation or timing of such discussions, or who should take responsibility for them. Introducing deactivation discussions prior to implantation was thus contentious; however, trigger points for deactivation discussions embedded within the pathway were suggested to ensure timely discussions. Limitations: Only two patients who were prospectively considering deactivation and seven bereaved relatives were recruited. The study also lacks the perspectives of primary care clinicians. Conclusions: There is discordance between patients and clinicians on information requirements, in particular the potential consequences of implantation on psychological well-being and quality of life in the short and long term (deactivation). There were no agreed points across the care pathway at which to discuss deactivation. Codesigned information tools that present balanced information on the benefits, risks and consequences, and SDM skills training for patients/relative and clinicians, would support better SDM about ICDs. Future work: Multifaceted SDM interventions that focus on skills development for SDM combined with decision-support tools are warranted, and there is a potential central role for heart failure nurses and physiologists in supporting and preparing patients/relatives for such discussions. Funding: The National Institute for Health Research Health Services and Delivery Research programme.
url https://doi.org/10.3310/hsdr04320
work_keys_str_mv AT hollystanding aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT catherineexley aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT darrenflynn aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT julianhughes aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT kerryjoyce aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT trudielobban aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT stephenlord aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT danielmatlock aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT janetmmccomb aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT paulpaes aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT richardgthomson aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT hollystanding qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT catherineexley qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT darrenflynn qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT julianhughes qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT kerryjoyce qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT trudielobban qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT stephenlord qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT danielmatlock qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT janetmmccomb qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT paulpaes qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
AT richardgthomson qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare
_version_ 1716809033969565696
spelling doaj-52bb92faeab9435185bd2c1cdfd072fe2020-11-24T20:48:03ZengNIHR Journals LibraryHealth Services and Delivery Research2050-43492050-43572016-10-0143210.3310/hsdr0432011/2004/29A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life careHolly Standing0Catherine Exley1Darren Flynn2Julian Hughes3Kerry Joyce4Trudie Lobban5Stephen Lord6Daniel Matlock7Janet M McComb8Paul Paes9Richard G Thomson10Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKPolicy, Ethics and Life Sciences Research Centre, Newcastle University, Newcastle upon Tyne, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKArrhythmia Alliance: The Heart Rhythm Charity, Stratford-upon-Avon, UKNewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USANewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKNorthumbria Healthcare NHS Foundation Trust, North Shields, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKBackground: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms, respectively. The pacing function may be very sophisticated and can provide so-called cardiac resynchronisation therapy for the treatment of heart failure using a pacemaker (cardiac resynchronisation therapy with pacemaker) or combined with an ICD [cardiac resynchronisation therapy with defibrillator (CRT-D)]. Decision-making about these devices involves considering the benefit (averting sudden cardiac death), possible risks (inappropriate shocks and psychological problems) and the potential need for deactivation towards the end of life. Objectives: To explore patients’/relatives’ and clinicians’ views/experiences of decision-making about ICD and CRT-D implantation and deactivation, to establish how and when ICD risks, benefits and consequences are communicated to patients, to identify individual and organisational facilitators and barriers to discussions about implantation and deactivation and to determine information and decision-support needs for shared decision-making (SDM). Data sources: Observations of clinical encounters, in-depth interviews and interactive group workshops with clinicians, patients and their relatives. Methods: Observations of consultations with patients being considered for ICD or CRT-D implantation were undertaken to become familiar with the clinical environment and to optimise the sampling strategy. In-depth interviews were conducted with patients, relatives and clinicians to gain detailed insights into their views and experiences. Data collection and analysis occurred concurrently. Interactive workshops with clinicians and patients/relatives were used to validate our findings and to explore how these could be used to support better SDM. Results: We conducted 38 observations of clinical encounters, 80 interviews (44 patients/relatives, seven bereaved relatives and 29 clinicians) and two workshops with 11 clinicians and 11 patients/relatives. Patients had variable knowledge about their conditions, the risk of sudden cardiac death and the clinical rationale for ICDs, which sometimes resulted in confusion about the potential benefits. Clinicians used various metaphors, verbal descriptors and numerical risk methods, including variable disclosure of the potential negative impact of ICDs on body image and the risk of psychological problems, to convey information to patients/relatives. Patients/relatives wanted more information about, and more involvement in, deactivation decisions, and expressed a preference that these decisions be addressed at the time of implantation. There was no consensus among clinicians about the initiation or timing of such discussions, or who should take responsibility for them. Introducing deactivation discussions prior to implantation was thus contentious; however, trigger points for deactivation discussions embedded within the pathway were suggested to ensure timely discussions. Limitations: Only two patients who were prospectively considering deactivation and seven bereaved relatives were recruited. The study also lacks the perspectives of primary care clinicians. Conclusions: There is discordance between patients and clinicians on information requirements, in particular the potential consequences of implantation on psychological well-being and quality of life in the short and long term (deactivation). There were no agreed points across the care pathway at which to discuss deactivation. Codesigned information tools that present balanced information on the benefits, risks and consequences, and SDM skills training for patients/relative and clinicians, would support better SDM about ICDs. Future work: Multifaceted SDM interventions that focus on skills development for SDM combined with decision-support tools are warranted, and there is a potential central role for heart failure nurses and physiologists in supporting and preparing patients/relatives for such discussions. Funding: The National Institute for Health Research Health Services and Delivery Research programme.https://doi.org/10.3310/hsdr04320